Matinas Biopharma Holdings, Inc (MTNB) Financials

MTNB Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 29.8 million 6.6 million
2023-06-30 34.0 million 6.2 million
2023-03-31 38.3 million 5.6 million
2022-12-31 44.8 million 8.2 million

MTNB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.4 million 1.2 million
2023-06-30 -2.4 million 1.2 million
2023-03-31 -4.1 million 1.3 million
2022-12-31 -4.3 million 1.3 million

MTNB Net Income

No data available :(

MTNB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 18.2 million - 3.7 million
2023-06-30 22.5 million - 3.9 million
2023-03-31 24.9 million - 4.0 million
2022-12-31 28.8 million - 4.1 million

MTNB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 217.3 million
2023-06-30 217.3 million
2023-03-31 217.3 million
2022-12-31 216.8 million

MTNB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 16000 3.3 million 2.8 million -
2023-06-30 202000 3.6 million 2.6 million -
2023-03-31 202000 4.0 million 2.7 million -
2022-12-31 41601 3.9 million 2.7 million -

MTNB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 238000
2023-06-30 - 234000
2023-03-31 1.1 million 229000
2022-12-31 1.1 million 3.5 million

MTNB

Price: $0.17

52 week price:
0.11
0.89

Earnings Per Share: -0.11 USD

P/E Ratio: -2.08

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 237100

Market Capitalization: 51.0 million

Links: